Search research articles
Contact Us
Filters
Showing results (1-10 of 170) with videos related to
Page
of 17
Sort By:
Epidemiologia E Prevenzione
|
March 7, 2003
[Risks and benefits of hormone replacement therapy: clinical considerations and research implications]
Andrea Decensi
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2009
The rationale and potential of cancer chemoprevention with special emphasis on breast cancer
Matteo Puntoni, Andrea Decensi
Cancer Prevention Research (Philadelphia, Pa.)
|
March 1, 2013
Allopurinol in subjects with colorectal adenoma--response
Matteo Puntoni, Andrea Decensi
Cancer Prevention Research (Philadelphia, Pa.)
|
February 1, 2019
An Abstract Provides "seAFOod" for Thought
Andrea DeCensi, Andreas Gescher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2010
Insulin breast cancer connection: confirmatory data set the stage for better care
Andrea DeCensi, Alessandra Gennari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ
Matteo Lazzeroni, Andrea DeCensi
Hematology/Oncology Clinics of North America
|
August 7, 2013
Breast cancer prevention by antihormones and other drugs: where do we stand?
Matteo Lazzeroni, Andrea DeCensi
Seminars in Oncology
|
March 13, 2016
Alternate dosing schedules for cancer chemopreventive agents
Matteo Lazzeroni, Andrea DeCensi
Current Opinion in Obstetrics & Gynecology
|
November 28, 2017
Endocrine therapy in ovarian cancer: where do we stand?
Laura Paleari, Andrea DeCensi
Cancer Prevention Research (Philadelphia, Pa.)
|
March 3, 2026
The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast Cancer
Andrea DeCensi, Matteo Lambertini
Page
of 17
Search research articles
Search
Showing results (1-10 of 170) with videos related to
Sort By:
Page
of 17
Epidemiologia E Prevenzione
|
March 7, 2003
[Risks and benefits of hormone replacement therapy: clinical considerations and research implications]
Andrea Decensi
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2009
The rationale and potential of cancer chemoprevention with special emphasis on breast cancer
Matteo Puntoni, Andrea Decensi
Cancer Prevention Research (Philadelphia, Pa.)
|
March 1, 2013
Allopurinol in subjects with colorectal adenoma--response
Matteo Puntoni, Andrea Decensi
Cancer Prevention Research (Philadelphia, Pa.)
|
February 1, 2019
An Abstract Provides "seAFOod" for Thought
Andrea DeCensi, Andreas Gescher
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 1, 2010
Insulin breast cancer connection: confirmatory data set the stage for better care
Andrea DeCensi, Alessandra Gennari
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 4, 2020
De-Escalating Treatment of Low-Risk Breast Ductal Carcinoma In Situ
Matteo Lazzeroni, Andrea DeCensi
Hematology/Oncology Clinics of North America
|
August 7, 2013
Breast cancer prevention by antihormones and other drugs: where do we stand?
Matteo Lazzeroni, Andrea DeCensi
Seminars in Oncology
|
March 13, 2016
Alternate dosing schedules for cancer chemopreventive agents
Matteo Lazzeroni, Andrea DeCensi
Current Opinion in Obstetrics & Gynecology
|
November 28, 2017
Endocrine therapy in ovarian cancer: where do we stand?
Laura Paleari, Andrea DeCensi
Cancer Prevention Research (Philadelphia, Pa.)
|
March 3, 2026
The Long and Winding Road toward Prevention of Estrogen Receptor-Negative and BRCA1-Associated Breast Cancer
Andrea DeCensi, Matteo Lambertini
Page
of 17